| | | Prevalence of antimicrobial use in hospitals in acute care hospitals in Europe, ECDC PPS 2011-2012 in Europe |
| | |
| | | | | | | | | | | Patients who received at least one antimicrobial agent (%) | | | < 30.0 | | | 30.0 to < 35.0 | | | 35.0 to < 40.0 | | | 40.0 to < 45.0 | | | ≥ 45.0 | | | No data reported | | | Not included |
| | | | | | | | | | Non-visible countries | | | Liechtenstein | | | Luxembourg | | | Malta |
| | | |
|
| | The Netherlands: data on antimycotics were not collected. Antimycotics represented 3.8% of antimicrobial use overall in other countries.
*Country representativeness of the PPS data was optimal or good in 25 (76%) countries, and poor or very poor in 8 (24%) countries. Countries (number of participating hospitals) with poor representativeness were: Austria (n=9), Croatia (n=11), Czech Republic (n=14), Estonia (n=4), Norway (n=7), Romania (n=10) and countries with very poor representativeness were Denmark (n=3) and Sweden (n=4) and are indicated by a “*” in maps and tables.Data from the ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals (ECDC PPS) in the period 2011-2012 as reported to TESSy as of 2013-02-06 14:06:48 |
|
|
| |
